Related Experiment Video
Updated: Aug 9, 2026
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
Langerhans' cell histiocytosis: report of a case with temporal localization
A Martini1, C Aimoni, M Trevisani
1Clinica Orl, Universita' degli Studi di Ferrara, C.so Giovecca 203, 44100 Ferrara, Italy.
Insights
This case study details a 12-year-old boy with rapidly progressing Langerhans' cell histiocytosis (LCH) affecting the temporal bone. Early diagnosis and treatment are crucial for this rare proliferative disorder.
Area of Science:
- Pediatric Oncology
- Histiocytosis Research
- Immunodermatology
Background:
- Langerhans' cell histiocytosis (LCH) is a rare proliferative disorder of unknown etiology.
- It involves cells with characteristics of normal Langerhans' cells, possibly due to immunoregulation defects.
- Head and neck involvement is common in LCH, particularly in males.
Observation:
- A 12-year-old boy presented with a rapidly evolving, unifocal, monosystemic LCH of the temporal bone.
- The case highlights a rare temporal bone localization of this disease.
- Clinical presentation was aggressive and rapidly progressive.
Findings:
- Diagnosis of LCH was confirmed by histopathologic findings and specific markers (ATPase, S 100, D-mannoxidase positivity).
- The study emphasizes the importance of recognizing LCH in the differential diagnosis of temporal bone lesions.
- Age at presentation typically ranges from infancy to 15 years.
Implications:
- This case underscores the need for prompt diagnostic evaluation in pediatric patients with rapidly progressing head and neck lesions.
- Understanding the clinical spectrum of LCH is vital for timely intervention.
- Further research into LCH etiology and pathogenesis may improve treatment strategies.
Abstract:
The authors report a case of Langerhans' cell histiocytosis (LCH) with temporal localization and rapidly evolving initial clinical presentation in a 12-year-old boy. This disease of currently unknown etiology is actually considered a proliferative entity of cells with phenotypic characteristics of normal Langerhans' cells. An immunoregulation defect leading to abnormal maturation and migration of Langerhans' cells might be the basis for LCH. According to the Hystiocyte Society diagnostic criteria, ATPase, S 100 and D-mannoxidase positivity in addition to typical hystopathologic findings are sufficient for diagnosis of LCH. Head and neck localization of LCH occurs in about 70% of cases; males are more frequently affected than females, age at presentation varies from a few months to 15 years. Presenting features, initial diagnostic evaluation, differential diagnosis and treatment protocol of a unifocal monosystemic temporal bone localization of LCH are presented.
